Guest lecturers: Fall 2021
Joshua Abram and Alan Murray, co-founders, TMRW Life Sciences
Piraye Beim, CEO, Celmatix
Jesse Beyroutey, general partner, IA Ventures
Chip Clark, president and CEO, Genocea Biosciences
Yazmin Feliz, biomedical engineer, alumna of BIOT4180
Michelle McMurray-Heath, president and CEO, Biotechnology Innovation Organization (BIO)
Norma Padron, healthcare economist, Anthem
Sarah Zhang, health and science writer, The Atlantic
Daphne Zohar, founder and CEO of PureTech Health
Piraye Beim, CEO, Celmatix
Jesse Beyroutey, general partner, IA Ventures
Chip Clark, president and CEO, Genocea Biosciences
Yazmin Feliz, biomedical engineer, alumna of BIOT4180
Michelle McMurray-Heath, president and CEO, Biotechnology Innovation Organization (BIO)
Norma Padron, healthcare economist, Anthem
Sarah Zhang, health and science writer, The Atlantic
Daphne Zohar, founder and CEO of PureTech Health
Guest lecturers: Spring 2020
Jacques Cohen, founder of Life Global, Alpha Environmental, Reprogenetics, co-founder or IRMS, Althea Science, ART Institute of Washington
Aparna Divaraniya, CEO of Oova
Alice Crisci, CEO of MedAnswers
Randi Hutter Epstein, medical writer, journalist, author of Aroused: The History of Hormones & How They Control Almost Everything
Harry Glorikian, New Ventures Funds, Author of Moneyball Medicine
Jamie Metzl, Atlantic Council, NSC, United Nations, State Department, author of Hacking Darwin
Paul Sehkri, CEO of eGenesis, president and CEO of Lycera, chief strategy officer Teva Pharmaceuticals, operating partner TPG Biotech
Luke Timmerman, journalist, entrepreneur, founder of the Timmerman Report, author of Hood
Aparna Divaraniya, CEO of Oova
Alice Crisci, CEO of MedAnswers
Randi Hutter Epstein, medical writer, journalist, author of Aroused: The History of Hormones & How They Control Almost Everything
Harry Glorikian, New Ventures Funds, Author of Moneyball Medicine
Jamie Metzl, Atlantic Council, NSC, United Nations, State Department, author of Hacking Darwin
Paul Sehkri, CEO of eGenesis, president and CEO of Lycera, chief strategy officer Teva Pharmaceuticals, operating partner TPG Biotech
Luke Timmerman, journalist, entrepreneur, founder of the Timmerman Report, author of Hood
Guest lecturers: Fall 2018
Gina Bartasi, founder and CEO of Kindbody, Progyny and Fertility Authority
Sally Church, BiotechStrategy, Targets podcast
Joel Dudley, Director of the Institute for Next Generation Healthcare at the Icahn School of Medicine at Mount Sinai
Damian Garde, StatNews
Buzzy Geduld, New York City legendary entrepreneur
David Hung, CEO Medivation
Fami Quadir, founder, chief investment officer, Safkhet Capital
Maithreyi Raman, ClearView Healthcare Partners, alumna of BIOT 4180
Nina Kaarina Roberts, writer and photographer, known for her work documenting immigrant entrepreneurs
Sally Church, BiotechStrategy, Targets podcast
Joel Dudley, Director of the Institute for Next Generation Healthcare at the Icahn School of Medicine at Mount Sinai
Damian Garde, StatNews
Buzzy Geduld, New York City legendary entrepreneur
David Hung, CEO Medivation
Fami Quadir, founder, chief investment officer, Safkhet Capital
Maithreyi Raman, ClearView Healthcare Partners, alumna of BIOT 4180
Nina Kaarina Roberts, writer and photographer, known for her work documenting immigrant entrepreneurs
Guest lecturers: Spring 2017
Alex Bisignano, co-founder and CEO, Phosphorus
Benjamin J. Davies, MD, Urologic Oncology, University of Pittsburgh School of Medicine, writer, innovator, Columbia grad
Aditya Julka, founder InBioPro, BioAtlantis, Paddle8.
Brad Loncar, founder Loncar Cancer Immunotherapy Index Fund
Anne Morriss, CEO, GenePeeks, Inc.
Jason Park, Flagship Ventures
Barry Rosenstein, founder and managing partner, JANA Partners LLC
Meg Tirrell, Biotechnology and Pharmaceutical Reporter, CNBC
Kevin Tyan, co-foudner Kinnos Healthcare, current Columbia student, alumnus of BIOT4180
Mi Wang, Gates Foundation, alumna of BIOT4180
Benjamin J. Davies, MD, Urologic Oncology, University of Pittsburgh School of Medicine, writer, innovator, Columbia grad
Aditya Julka, founder InBioPro, BioAtlantis, Paddle8.
Brad Loncar, founder Loncar Cancer Immunotherapy Index Fund
Anne Morriss, CEO, GenePeeks, Inc.
Jason Park, Flagship Ventures
Barry Rosenstein, founder and managing partner, JANA Partners LLC
Meg Tirrell, Biotechnology and Pharmaceutical Reporter, CNBC
Kevin Tyan, co-foudner Kinnos Healthcare, current Columbia student, alumnus of BIOT4180
Mi Wang, Gates Foundation, alumna of BIOT4180
Guest lecturers: Fall 2014
Katrine Bosley, CEO Avila Therapeutics, board chair Genocea, Entrepreneur-in-residence Broad Institute
Josh Brown, author of Backstage Wall Street and Clash of the Financial Pundits; writer/blogger/CNBC contributor/advisor
Jane Hyun, President Hyun Associates, author "Breaking the Bamboo Ceiling" and "Flex: The New Playbook for Managing Across Differences"
Paul Maddon, entrepreneur, CEO Progenics Pharmaceuticals, Columbia graduate and trustee
Ankit Mahadevia, MD, venture partner, Atlas Venture
Samuel K. Sia, associate professor, department of biomedical engineering, Columbia; founder, Harlem Biospace
Mark Schoenebaum, Senior Managing Director, ISI, Health Care Research
Barbara Yanni, VP and chief licensing officer, Merck & Co.
Josh Brown, author of Backstage Wall Street and Clash of the Financial Pundits; writer/blogger/CNBC contributor/advisor
Jane Hyun, President Hyun Associates, author "Breaking the Bamboo Ceiling" and "Flex: The New Playbook for Managing Across Differences"
Paul Maddon, entrepreneur, CEO Progenics Pharmaceuticals, Columbia graduate and trustee
Ankit Mahadevia, MD, venture partner, Atlas Venture
Samuel K. Sia, associate professor, department of biomedical engineering, Columbia; founder, Harlem Biospace
Mark Schoenebaum, Senior Managing Director, ISI, Health Care Research
Barbara Yanni, VP and chief licensing officer, Merck & Co.
Guest lecturers: Fall 2013
Michael Gilman, CEO and founder Stromedix; CSO at Ariad, VP research Biogen Idec
Matthew Herper, MIT, Columbia J School; covers medicine and science for Forbes
Peter Kolchinsky, founding partner and portfolio manager, RA Capital
Saira Ramasastry, managing partner, Life Sciences Advisory (strategy, banking)
Samuel K. Sia, associate professor, department of biomedical engineering, Columbia; founder, Harlem Biospace
Jeffrey M. Sears, Associate General Counsel and Chief Patent Counsel forColumbia University
Nancy Simonian, CEO of Syros
Nina Tandon, Co-founder EpiBone; Cooper Union and Columbia faculty
Matthew Herper, MIT, Columbia J School; covers medicine and science for Forbes
Peter Kolchinsky, founding partner and portfolio manager, RA Capital
Saira Ramasastry, managing partner, Life Sciences Advisory (strategy, banking)
Samuel K. Sia, associate professor, department of biomedical engineering, Columbia; founder, Harlem Biospace
Jeffrey M. Sears, Associate General Counsel and Chief Patent Counsel forColumbia University
Nancy Simonian, CEO of Syros
Nina Tandon, Co-founder EpiBone; Cooper Union and Columbia faculty
Guest lecturers: Spring 2013
Michelle Dipp, CEO of OvaScience and partner, Longwood Fund (life sciences executive and venture capital)
Pam Feliciano, associate editor, Nature Genetics, PhD in developmental biology (Stanford)
Gonzalo Merino, Columbia technology transfer office (patents and intellectual property) (Columbia grad)
Heidi N. Moore, finance and economics editor, The Guardian (media, strategy, idea generation) (Columbia grad)
Diem Nguyen, general manager, biosimilars, Pfizer (pharmaceutical development), PhD in biochemistry (U Virginia)
Dennis Purcell, senior managing partner, Aisling Capital (venture capital)
Avik Roy, writer, commentator, analyst, founder of Roy Healthcare Research
Y. Katherine Xu, PhD, biotechnology analyst, William Blair & Company (research analyst)
Pam Feliciano, associate editor, Nature Genetics, PhD in developmental biology (Stanford)
Gonzalo Merino, Columbia technology transfer office (patents and intellectual property) (Columbia grad)
Heidi N. Moore, finance and economics editor, The Guardian (media, strategy, idea generation) (Columbia grad)
Diem Nguyen, general manager, biosimilars, Pfizer (pharmaceutical development), PhD in biochemistry (U Virginia)
Dennis Purcell, senior managing partner, Aisling Capital (venture capital)
Avik Roy, writer, commentator, analyst, founder of Roy Healthcare Research
Y. Katherine Xu, PhD, biotechnology analyst, William Blair & Company (research analyst)
Guest lecturers: 2012
Ritu Baral, analyst at Cannacord Adams (biotechnology equity research)
Adam Feuerstein, biotech writer for TheStreet.com (media)
Carl Gordon, General partner, OrbiMed (venture capital, private equity)
Richard E. Gormley, Managing Director, Lazard Freres & Co. (investment banking)
Jim Greenwood, CEO of BIO (tentative) (industry-government relations)
Mike Huckman, MSL Group and CNBC pharmaceuticals reporter and analyst (media)
Gonzalo Merino, Columbia technology transfer office (patents and intellectual property)
Rory Riggs (multi)
Sandra Silberman, VP of Oncology, Quintiles (pharmaceutical development)
Shirley Wang, Wall Street Journal (media)
Adam Feuerstein, biotech writer for TheStreet.com (media)
Carl Gordon, General partner, OrbiMed (venture capital, private equity)
Richard E. Gormley, Managing Director, Lazard Freres & Co. (investment banking)
Jim Greenwood, CEO of BIO (tentative) (industry-government relations)
Mike Huckman, MSL Group and CNBC pharmaceuticals reporter and analyst (media)
Gonzalo Merino, Columbia technology transfer office (patents and intellectual property)
Rory Riggs (multi)
Sandra Silberman, VP of Oncology, Quintiles (pharmaceutical development)
Shirley Wang, Wall Street Journal (media)
Guest lecturers: 2011
Martin Vogelbaum, partner, rho Ventures (venture capital)
Jonathan Fassberg, CEO of the Trout Group (fundraising)
Gonzalo Merino, Columbia technology transfer office (patents and intellectual property)
Lily Kim, PhD, independent consultant in microfluidics (start-up)
Spiro Rombotis, CEO, Cyclacel (public company CEO)
Ritu Baral, analyst at Cannacord Adams (investment banking, equity research)
Adam Feuerstein, biotech writer for TheStreet.com (biotech journalism)
Mike Huckman, pharmaceutical industry public relations, CNBC reporter
Jim Greenwood, CEO of BIO (industry organization, government regulation)
Jonathan Fassberg, CEO of the Trout Group (fundraising)
Gonzalo Merino, Columbia technology transfer office (patents and intellectual property)
Lily Kim, PhD, independent consultant in microfluidics (start-up)
Spiro Rombotis, CEO, Cyclacel (public company CEO)
Ritu Baral, analyst at Cannacord Adams (investment banking, equity research)
Adam Feuerstein, biotech writer for TheStreet.com (biotech journalism)
Mike Huckman, pharmaceutical industry public relations, CNBC reporter
Jim Greenwood, CEO of BIO (industry organization, government regulation)
